A cognitive regulatory control model of schizophrenia

Brain Research Bulletin

Volumn 85, Issue 1-2, 2011, Pages 36-41

  Bowins, Brad ^a  

^a Private psychiatrist   (Canada)

Author keywords

Defense mechanisms; Delusions; Hallucinations; Negative symptoms; Positive symptoms; Psychosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADAPTIVE BEHAVIOR; BIPOLAR DISORDER; COGNITIVE DEFECT; DEFENSE MECHANISM; DELIRIUM; DELUSION; DELUSIONAL DISORDER; DEMENTIA; EXECUTIVE FUNCTION; FANTASY; GRIEF; HUMAN; INTELLIGENCE; NEUROLOGIC DISEASE; PARANOID PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SENSORY STIMULATION; SLEEP WAKING CYCLE;

COGNITION; COGNITION DISORDERS; HUMANS; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 79954629350     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.02.004     Document Type: Review

References (88)

1. Addington J., Addington D. Three-year outcome of treatment in an early psychosis program. Can. J. Psychiatry 2009, 54:626-630.
2. Amador X.F., Kirkpatrick B., Buchanon R.W., Carpenter W.T., Marcinko L., Yale S.A. Stability of the diagnosis of deficit syndrome in schizophrenia. Am. J. Psychiatry 1999, 156(4):637-639.
3. Andreasen N.C., Flashman L., Flaum M., Arndt S.T., Swayze V., O'Leary D.S. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA 1994, 272:1763-1773.
4. Andreasen N.C., O'Leary D.S., Flaum M. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic naive patients. Lancet 1997, 349:1730-1734.
5. Arango C., Buchanan R.W., Kirkpatrick B., Carpenter W.T. The deficit syndrome in schizophrenia: implications for the treatment of negative symptoms. Eur. Psychiatry 2004, 19:21-26.
6. Barish D.P. Sociobiology and Behavior 1982, Elsevier, New York.
7. Bemporad J.R. Dementia praecox as a failure of neoteny. Theor. Med. 1991, 12:45-51.
8. Bentall R.P., Kinderman P., Kaney S. The self, attributional processes and abnormal beliefs: towards a model of persecutory delusions. Behav. Res. Ther. 1994, 32:331-341.
9. Bertolino A., Kumra S., Callicot J.H., Mattay V.S., Lestz R.M., Jacobsen L., et al. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry 1998, 155:1376-1383.
10. Bilder R.M., Goldman R.S., Robinson D., Reiter G., Bell L., Bates J.A., et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am. J. Psychiatry 2000, 157:549-559.
11. Bowers M. Retreat from Sanity 1973, Behavioral Publications, New York.
12. Bowins B.E. Psychological defense mechanisms: a new perspective. Am. J. Psychoanal. 2004, 64:1-26.
13. Bowins B.E. How psychiatric treatments can enhance psychological defense mechanisms. Am. J. Psychoanal. 2006, 66:173-194.
14. Bowins B.E. Personality disorders: a dimensional defense mechanism approach. Am. J. Psychother. 2010, 64(2):153-169.
15. Bowins B., Shugar G. Delusions and self-esteem. Can. J. Psychiatry 1998, 43:154-158.
16. Buchanan R.W., Kirkpatrick B., Heinrichs R.W., Carpenter W.T. Clinical correlates of the deficit syndrome in schizophrenia. Am. J. Psychiatry 1990, 147:290-294.
17. Carpenter W.T., Arango C., Buchanan R.W., Kirkpatrick B. Deficit psychopathology and a paradigm shift in schizophrenic research. Biol. Psychiatry 1999, 46:352-360.
18. Carpenter W.T., Heinrichs D.W., Wagman A.M. Deficit and nondeficit forms of schizophrenia: the concept. Am. J. Psychiatry 1988, 145:578-583.
19. Chapman L.J., Chapman J.P. Scales for rating psychotic and psychotic-like experiences as continua. Schizophr. Bull. 1980, 6:476-489.
20. Choong C., Hunter M.D., Woodruff P.W. Auditory hallucinations in those populations that do not suffer from schizophrenia. Curr. Psychiatry Rep. 2007, 9:206-212.
21. Davidson M., Galderisi S., Weiser M., Werbeloff N., Fleishhacker W.W., Keefe R.S., et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open label clinical trial (EUFEST). Am. J. Psychiatry 2009, 166:675-682.
22. Davies M., Coltheart M., Langdon R., Breen N. Monothematic delusions: towards a two-factor account. Philos. Psychiatry Psychol. 2001, 8:133-158.
23. Dickinson D., Tenhula W., Morris S., Brown C., Peer J., Spencer K., et al. A randomized controlled trial of computer-assisted cognitive remediation for schizophrenia. Am. J. Psychiatry 2010, 167:170-180.
24. Dietrich A. Functional neuroanatomy of altered states of consciousness: the transient hypofrontality hypothesis. Conscious. Cogn. 2003, 12:231-256.
25. Donohoe G., Corvin A., Robertson I.H. Evidence that specific executive functions predict symptom variance among schizophrenic patients with a predominantly negative symptom profile. Cogn. Neuropsychiatry 2006, 11:13-32.
26. Elvevag B., Goldberg T.E. Cognitive impairment in schizophrenia is the core of the disorder. Crit. Rev. Neurobiol. 2000, 14:1-21.
27. Fenton W.S., McGlashan T.H. Antecedents, symptom progression, and long-term outcome in the deficit syndrome in schizophrenia. Am. J. Psychiatry 1994, 151:351-356.
28. First M.B., Frances A., Pincus H.A. DSM-IV-TR Handbook of Differential Diagnosis 2002, American Psychiatric Publishing Inc., Washington, DC.
29. Fiszdon J.M., Richardson R., Greig T., Bell M.D. A comparison of basic and social cognition between schizophrenia and schizoaffective disorder. Schizophr. Res. 2007, 91:117-121.
30. Ford J.M., Mathalon D.H. Electrophysiological evidence of corollary discharge dysfunction in schizophrenia during talking and thinking. J. Psychiatry Res. 2004, 38:37-46.
31. Frith C.D. The Cognitive Neuropsychology of Schizophrenia 1992, Lawrence Erlbaum Associates Ltd., Hove, UK.
32. Fuster J.M. The prefrontal cortex-an update: time is of the essence. Neuron 2001, 30:319-333.
33. Galletly C. Recent advances in treating cognitive impairment in schizophrenia. Psychopharmacology 2009, 202:1302-1309.
34. Garety P., Freeman D. Cognitive approaches to delusions: a critical review of theories and evidence. Br. J. Clin. Psychol. 1999, 38:113-154.
35. Garety P., Hemsley D.R. Characteristics of delusional experience. Eur. Arch. Gen. Psychiatry Neurol. Sci. 1987, 236:294-298.
36. Garety P.A., Hemsley D.R., Wessely S. Reasoning in deluded schizophrenic and paranoid patients: biases in performance on a probabilistic inference task. J. Nerv. Ment. Dis. 1991, 179:194-201.
37. Goff D.C., Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry 2001, 158(9):1367-1377.
38. Gupta S., Kulhara P. What is schizophrenia: a neurodevelopmental or neurodegenerative disorder or combination of both. A critical analysis. Indian J. Psychiatry 2010, 52(1):21-27.
39. Helldin L., Kane J.M., Karilampi U., Norlander T., Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. J. Psychiatr. Res. 2006, 40:738-745.
40. Hemmingsen R., Madsen A., Glenthoj B., Rubin P. Cortical brain dysfunction in early schizophrenia: secondary pathogenetic hierarchy of neuroplasticity, psychopathology and social impairment. Acta Psychiatry Scand. 1999, 99(Suppl. 395):80-88.
41. Heresco-Levy U., Javitt D.C., Ermilov M., Mordel C., Silipo G., Lichenstein M. Efficacy of high dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch. Gen. Psychiatry 1999, 56(1):29-36.
42. Ho B.C., Nopoulos P., Flaum N., Arudt S., Andreasen N.C. Two year outcome in first episode schizophrenia: predictive value of symptoms for quality of life. Am. J. Psychiatry 1998, 155:1196-1201.
43. Hobson J.A., Pace-Schott E.F., Stickhold R. Dreaming and the brain: towards a cognitive neuroscience of conscious states. Behav. Brain Sci. 2000, 23:793-866.
44. Horan W.P., Blanchard J.J. Neurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia. Schizophr. Res. 2003, 65:125-137.
45. Javitt D.C. Glycine transport inhibitors and the treatment of schizophrenia. Biol. Psychiatry 2008, 63:6-8.
46. Johns L.C., van Os J. The continuity of psychotic experiences in the general population. Clin. Psychol. Rev. 2001, 21:1125-1141.
47. Kaney S., Bentall R.P. Persecutory delusions and the self-serving bias: evidence from a contingency judgment task. J. Nerv. Ment. Dis. 1992, 180:773-780.
48. Keefe R.S., Fenton W.S. How should DSM-V criteria for schizophrenia include cognitive impairment?. Schizophr. Bull. 2007, 33:912-920.
49. Khaitovich P., Lockstone H.E., Wayland M.T. Metabolic changes in schizophrenia and human brain evolution. Genome Biol. 2008, 9(8):273-285.
50. Kirkpatrick B., Buchanan R.W. The neural basis of the deficit syndrome of schizophrenia. J. Nerv. Ment. Dis. 1990, 178(9):545-555.
51. Kirkpatrick B., Buchanan R.W., McKenney P.D., Alpha L.D., Carpenter W.T. The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989, 30(2):119-123.
52. Kirkpatrick B., Buchanan R.W., Ross D.E., Carpenter W.T. A separate disease within the syndrome of schizophrenia. Arch. Gen. Psychiatry 2001, 58:165-171.
53. Kirkpatrick B., Castle D., Murray R.M., Carpenter W.T. Risk factors for the deficit syndrome of schizophrenia. Schizophr. Bull. 2000, 26:233-242.
54. Kirkpatrick B., Ross D.E., Walsh D., Karkowski L., Kendler K.S. Family characteristics of deficit and nondeficit in schizophrenia in Roscommon family study. Schizophr. Res. 2000, 45:57-64.
55. Konner M. The Tangled Wing: Biological Constraints on the Human Spirit 1982, Harper & Row Publishers, New York.
56. Kulhara P., Chandiramani K. Positive and negative subtypes of schizophrenia. A follow-up study from India. Schizophr. Res. 1990, 3(2):107-116.
57. Lahti A.C., Holocomb H.H., Medoff D.R., Weiler M.A., Tamminga C.A., Carpenter W.T. Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an auditory recognition task. Am. J. Psychiatry 2001, 158:1797-1808.
58. Lane H., Chang Y., Liu Y., Chiu C., Guochan T. Sarcosine or d-serine add-on treatment for acute exacerbation of schizophrenia. Arch. Gen. Psychiatry 2005, 62(11):1196-1204.
59. Lawrence C. Hearing voices in a non-psychiatric population. Behav. Cogn. Psychol. 2010, 38:363-373.
60. Lewis D., Guillermo G.B. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacol. Rev. 2008, 33:141-165.
61. Lhermitte F., Pillon B., Serdaru M. Human autonomy and the frontal lobes. Part I: imitation and utilization behavior: a neuropsychological study of 75 patients. Ann. Neurol. 1986, 19:326-334.
62. Lucas S., Fitzgerald D., Redoblado-Hodge A., Anderson J., Sanbrook M., Harris A., et al. Neuropsychological correlates of symptom profiles in first episode schizophrenia. Schizophr. Res. 2004, 71:323-330.
63. Mahurin R.K., Velligan D.I., Miller A.L. Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis. Psychiatry Res. 1998, 79:139-149.
64. Malaspina D., Coleman E. Olfaction and social drive in schizophrenia. Arch. Gen. Psychiatry 2003, 60:578-584.
65. McCullumsmith R.E., Clinton S.M., Meador-Woodruff J.H. Schizophrenia as a disorder of neuroplasticity. Int. Rev. Neurobiol. 2004, 59:19-45.
66. McGlashan T.H., Hoffman R.E. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch. Gen. Psychiatry 2000, 57:637-648.
67. Mesulam M. Brain, mind, and the evolution of connectivity. Brain Cogn. 2000, 42:4-6.
68. Molina V., Sanz J., Reig S., Martinez R., Sarramea F., Luque R., et al. Hypofrontality in men with first-episode psychosis. Br. J. Psychiatry 2005, 186:203-208.
69. Morice R., Delahunty A. Frontal/executive impairments in schizophrenia. Schizophr. Bull. 1996, 22:125-137.
70. Morsella E., Krieger S.C., Bargh J.A. Minimal neuroanatomy for a conscious brain: homing in on the networks constituting consciousness. Neural Netw. 2010, 23:14-15.
71. Myers R.E., Swett C., Miller M. Loss of social group affinity following prefrontal lesions in free-ranging macaques. Brain Res. 1973, 64:257-269.
72. Olson P.R., Suddeth J.A., Peterson P.J. Hallucinations of widowhood. J. Am. Ger. Soc. 1985, 33:543-547.
73. Palmer B.W., McClure F.S., Jeste D.V. Schizophrenia in late life: findings challenge traditional concepts. Harv. Rev. Psychiatry 2001, March/April:51-58.
74. Pani L., Pira L., Marchese G. Antipsychotic efficacy: relationship to optimal D2-receptor occupancy. Eur. Psychiatry 2007, 22:267-275.
75. Pinikahana J., Happell B., Hope J., Keks N.A. Quality of life in schizophrenia: a review of the literature from 1995-2000. Int. J. Ment. Health Nurs. 2002, 11:103-111.
76. Ragland J.D., Laird A.R., Ranganath C., Blumenfeld R.S., Gonzales S.M., Glahn D.C. Prefrontal activation deficits during episodic memory in schizophrenia. Am. J. Psychiatry 2009, 166:863-874.
77. Reichenberg A., Caspi A., Harrington H., Houts R., Keefe R., Murray R., et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am. J. Psychiatry 2010, 167:160-169.
78. Rossi A., Daneluzzo E., Mattei P., Bustini M., Casacchia M., Stratta P. Wisconsin card sorting test and Stroop test performances in schizophrenia: a shared construct. Neurosci. Lett. 1997, 226:87-90.
79. Solms M., Turnbill O. The Brain and the Inner World 2002, Other Press, New York.
80. Steiner H., Araujo K., Koopman C. The response evaluation measure (REM-71): a new instrument for the measurement of defenses in adults and adolescents. Am. J. Psychiatry 2001, 158:467-473.
81. Stip E., Letourneau G. Psychotic symptoms as a continuum between normality and pathology. Can. J. Psychiatry 2009, 54:140-151.
82. Strauss J.S. Hallucinations and delusions as points on continua function. Arch. Gen. Psychiatry 1969, 21:581-586.
83. Strauss G.P., Harrow M., Grossman L., Rosen C. Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study. Schizophr. Bull. 2010, 36(4):788-799.
84. Suddath R.L., Cassanova M.F., Goldberg T.E., Daniel D.G., Kelsoe J.R., Weinberger D.R. Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. Am. J. Psychiatry 1989, 146:464-474.
85. Vaiva G., Cottencin O., Llorca P.M. Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria. Prog. Neuro-psychopharmacol. 2002, 26:481-485.
86. Weinberger D.R., Berman K.F., Zec R.F. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry 1986, 43:114-125.
87. Woo T.U., Crowell A.L. Targeting synapses and myelin in the prevention of schizophrenia. Schizophr. Res. 2005, 73:193-207.
88. Xiberas X., Martinot J.L., Mallet L., Artiges E., Loc H.C., Maziere B. Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. Br. J. Psychiatry 2001, 179:503-508.